ArticleThe EMBO journal1997
Cytoplasmic domains of the common beta-chain of the GM-CSF/IL-3/IL-5 receptors that are required for inducing differentiation or clonal suppression in myeloid leukaemic cell lines.
Article in The EMBO journal, 1997. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
12 citing papers in PubMed, 68 citations in OpenAlex.
- Claudin-Low Breast Cancer Inflammatory Signatures Support Polarization of M1-Like Macrophages with Protumoral Activity.Cancers · 2021Article
- Divergent effects of Wnt5b on IL-3- and GM-CSF-induced myeloid differentiation.Cellular signalling · 2020Article
- The GM-CSF receptor utilizes β-catenin and Tcf4 to specify macrophage lineage differentiation.Differentiation; research in biological diversity · 2012Article
- Article
- Hematopoietic cytokine receptor signaling.Oncogene · 2007Review
- Towards predictive models of stem cell fate.Cytotechnology · 2003Article
- Dissection of the cytoplasmic domains of cytokine receptors involved in STAT and Ras dependent proliferation.Oncogene · 2002Article
- JAKs, STATs and Src kinases in hematopoiesis.Oncogene · 2002Review
- Janus kinases: components of multiple signaling pathways.Oncogene · 2000Review
- IL-3 signaling and the role of Src kinases, JAKs and STATs: a covert liaison unveiled.Oncogene · 2000Review
- Expression of BCR - ABL in M1 myeloid leukemia cells induces differentiation without arresting proliferation.Oncogene · 1999Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 1 institution in 1 country.
Funding
Abstract
Granulocyte-macrophage colony stimulating factor (GM-CSF) is a cytokine that controls the production and function of myeloid cells by interaction with a cell surface receptor composed of a specific ligand-binding alpha-chain (hGMRalpha) and a shared signal-transducing beta-chain (beta c). Co-expression of human GMR alpha-chain and wild-type human beta c in two murine leukaemic cell lines (M1 and WEHI-3B D+) conferred the ability to terminally differentiate into macrophages when stimulated with human GM-CSF. Analysis of cytoplasmic truncation mutants of beta c showed that residues to amino acid 783 (numbering from the first amino acid of the leader sequence) were sufficient for the GM-CSF-dependent induction of all aspects of differentiation in both cell types. However, shorter truncations selectively lost, in a cell-specific manner, first the capacity to induce macrophage migration in agar and then cell surface differentiation antigens and clonal suppression of proliferative potential. The data suggest that different aspects of the differentiated phenotype can be dissociated with the required signalling pathways originating from distinct regions of the receptor cytoplasmic domain and cooperating to produce a fully differentiated macrophage. The cooperativity of these pathways and limiting cell signalling intermediate pool sizes could explain the observed cell line differences and may have implications for normal haemopoiesis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.